Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | BMC Genomics

Figure 4

From: Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers

Figure 4

A. Genotyping of strains evaluated by VNTR. Based on the limit of clonality of the assay (0.1 unit of divergence) [77], our collection contains at least 4 unrelated genetic backgrounds (noted A-D). Control strains whose genome has been sequenced have been simultaneously analyzed. B. Gene expression of identified markers on a collection of strains showing altered susceptibility to glycopeptides. Relative expression of 6 gene markers found up-regulated in the resistant strain 14-4 compared to the two sensitive strains. The same markers were also quantified in a collection of strains from the NARSA, selected for their resistance to glycopeptide. Values are mean + standard deviation of triplicate measurements from 2 independent experiments. Increase expression of selected markers, linked to glycopeptide resistance is independent on the background. The complete raw microarray dataset has been posted on the Gene Expression Omnibus database [78], accession number GSE5188. All additional files are freely accessible [79].

Back to article page